Grantham, Mayo, Van Otterloo & Co (GMO)
MJN

Grantham, Mayo, Van Otterloo & Co (GMO)’s Mead Johnson Nutrition Company MJN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-827,200
Closed -$73.7M – 667
2017
Q1 		$73.7M Buy
+827,200
New +$68M 0.42% 62
2014
Q3 		– Sell
-43,300
Closed -$4.03M – 506
2014
Q2 		$4.03M Sell
43,300
-5,100
-11% -$446K 0.01% 297
2014
Q1 		$4.02M Sell
48,400
-30,810
-39% -$2.5M 0.01% 326
2013
Q4 		$6.63M Buy
79,210
+40,357
+104% +$3.29M 0.02% 259
2013
Q3 		$2.88M Sell
38,853
-181,110
-82% -$13.6M 0.01% 376
2013
Q2 		$17.4M Buy
+219,963
New +$17.6M 0.05% 149

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MJN Position: Q2 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 827,200 shares — an estimated $73.7M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MJN in Q2 2013 and held it in 6 quarters. The position peaked at $73.7M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 827,200 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $73.7M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 6 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Mead Johnson Nutrition Company position peaked at $73.7M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2017, filed 14 Aug 2017.